|CrossRef Text and Data Mining|
|Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.|
|A Novel Therapeutic Target in Inflammatory Uveitis: Transglutaminase 2 Inhibitor|
|Joonhong Sohn, Ju Byung Chae, Sun Young Lee, Soo-Youl Kim, June-Gone Kim|
Korean J Ophthalmol. 2010;24(1):29-34. Published online February 5, 2010
A Novel Therapeutic Target in Inflammatory Uveitis: Transglutaminase 2 Inhibitor
Biological Therapies that Target Inflammatory Cytokines to Treat Uveitis
Inflammatory monocytes—a novel therapeutic target for ALS?
Knockout of tissue transglutaminase ameliorates TGFβ2-induced ocular hypertension: A novel therapeutic target for glaucoma?
Sphingolipids as mediators of inflammation and novel therapeutic target in inflammatory bowel disease
New therapeutic target in inflammatory disease: macrophage migration inhibitory factor
Complement inhibitor CD55 and progesterone receptors as a novel therapeutic target for lipoxin A4 in endotoxin mediated inflammatory stress
Oral voclosporin: novel calcineurin inhibitor for treatment of noninfectious uveitis
Tu1879 Legumain Is a Novel Biomarker and Therapeutic Target in Inflammatory Bowel Disease
Tu1663 MOSPD2: A NOVEL THERAPEUTIC TARGET FOR THE TREATMENT OF INFLAMMATORY DIGESTIVE DISORDERS